Litcius/Paper detail

Current status of phase 3 clinical trials in high-risk myelodysplastic syndromes: pitfalls and recommendations

Guillermo Garcia‐Manero

2022The Lancet Haematology20 citationsDOI

Topics & Concepts

Myelodysplastic syndromesMedicineHypomethylating agentClinical trialDecitabineOncologyIntensive care medicineInternal medicineBone marrowGeneChemistryBiochemistryGene expressionDNA methylationAcute Myeloid Leukemia ResearchCancer Genomics and DiagnosticsEpigenetics and DNA Methylation
Current status of phase 3 clinical trials in high-risk myelodysplastic syndromes: pitfalls and recommendations | Litcius